Page last updated: 2024-10-25

deferoxamine and Myoglobinuria

deferoxamine has been researched along with Myoglobinuria in 4 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Myoglobinuria: The presence of MYOGLOBIN in URINE usually as a result of rhabdomyolysis.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Plotnikov, EY1
Chupyrkina, AA1
Pevzner, IB1
Isaev, NK1
Zorov, DB1
Groebler, LK1
Liu, J1
Shanu, A1
Codd, R1
Witting, PK1
Zager, RA2
Burkhart, KM1
Conrad, DS1
Gmur, DJ1

Other Studies

4 other studies available for deferoxamine and Myoglobinuria

ArticleYear
Myoglobin causes oxidative stress, increase of NO production and dysfunction of kidney's mitochondria.
    Biochimica et biophysica acta, 2009, Volume: 1792, Issue:8

    Topics: Animals; Antioxidants; Cell Respiration; Deferoxamine; Free Radical Scavengers; Humans; Iron Chelati

2009
Comparing the potential renal protective activity of desferrioxamine B and the novel chelator desferrioxamine B-N-(3-hydroxyadamant-1-yl)carboxamide in a cell model of myoglobinuria.
    The Biochemical journal, 2011, May-01, Volume: 435, Issue:3

    Topics: Animals; Cell Line; Chelating Agents; Deferoxamine; Dogs; Endocytosis; Epithelial Cells; Gene Expres

2011
Iron, heme oxygenase, and glutathione: effects on myohemoglobinuric proximal tubular injury.
    Kidney international, 1995, Volume: 48, Issue:5

    Topics: Animals; Cell-Free System; Deferoxamine; Free Radical Scavengers; Glutathione; Glycerol; Heme Oxygen

1995
Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications.
    The Journal of clinical investigation, 1992, Volume: 90, Issue:3

    Topics: Acute Kidney Injury; Animals; Deferoxamine; Drug Therapy, Combination; Hydrogen Peroxide; Hydroxides

1992